Skip to content
What we learned on Day 1 of the Patient and Health Advocacy Summit
What did we learn on Day 1 of the Biotechnology Innovation Organization (BIO) ...
Read More
Expanding WTO IP waiver would hurt SMEs, CSBA tells Biden
Every member of the Council of State Bioscience Associations (CSBA) signed a letter to ...
Read More
State policies impacting access to innovative medicine, panel says
With issues like Accelerated Approval, anti-vaccine legislation, and biomarkers being taken up in ...
Read More
‘Goldilocks drug’ stops triple-negative breast cancer in mice, researchers say
A team of University of Arizona researchers using new knowledge about genes has ...
Read More
BIO’s patient advocacy event kicks off – don’t just be patient-centric, be patient-eccentric!
The Biotechnology Innovation Organization (BIO) kicked off Day One of its two-day Patient ...
Read More
WHO releases first-ever list of fungal priority pathogens
The World Health Organization (WHO) published the first list of fungal priority pathogens ...
Read More
EDITORS' CHOICE
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top priorities ...
Read More
LATEST NEWS
Federal Policy
Why reauthorization of the Rare Pediatric Disease Priority Review Voucher (PPRV) Program is vital
The Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PPRV) Program was top of mind during BIO’s March Patient Advocacy Coffee Chat: ...
Agriculture
National Biobased Products Day: Building better with biology
Whether it’s bottles, baby wipes, fashion, or fuel, biology can build it better. Biobased products, made from renewable natural materials, provide sustainable alternatives to products ...
Diversity, Equity, Inclusion
International Women’s Day: Improving women’s health by addressing autoimmune disease
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases – ...
Federal Policy
House members urge passage of reforms at PBM hearing
The time has come for Congress to pass legislation to prevent pharmacy benefit managers (PBMs) from inflating drug costs, limiting patient access to drugs, and ...
Health
EPIC Act introduced to correct IRA’s ‘pill penalty’
Bipartisan legislation reintroduced in the House on Feb. 21 would encourage the development of small-molecule drugs by eliminating the “pill penalty” in the Inflation Reduction ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President ...
Read More
International
Bio's View
BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan
February 28 is Rare Disease Day, and in observance, the Biotechnology Innovation Organization (BIO) is highlighting how it is working ...
Read More
